LumaCare News and Events
Product Info News and Events Concept Intellectual Property   Investment Opportunities   Related Info Team Contact Us Home			NEWS and EVENTS      See us in Hall13 / Stand B62-5 in partnership with Lynton Lasers, LumaCare’s UK Distributor ALSO: LumaCare is a sponsor of the 24th Annual VCS Conference in Kansas City, MO November 4-6, 2004. Web site: http://www.vetcancersociety.org More information . . .      Model LC-122M Achieves Medical Device Directive      See the LC122M at the ASP Meeting See Us At: MEDICA Nov. 24-27, 2004! LumaCare Press Releases March 30, 2004 Lumacare(r) announces that the LC-122M non-coherent PDT activation device has received CE Medical approval. The approval stems from the usage of the LC-122M to activate Photodynamic protocols such as: ALA, 5-ALA, Foscan(r), Levulan(r), Metex(r), Photofrin(r), and others, "We have finally proven that a non-coherent light source can activate PDT protocols without an expensive, potentially dangerous laser." November 21, 2001 LumaCare exhibits products at Medica 2001, the 33rd World Forum for Doctors' Surgeries and Hospitals at the Düsseldorf Trade Fair Centre. May 30, 2001 LumaCare LC-122 to Be Displayed at IPA Congress in June: Latest Non-coherent Light Source Provides Affordable PDT Activation April 21, 2000 LumaCare® Lamp Selected for PDT Lung Cancer Research at the University of Pennsylvania Medical Center August 1, 1998 Ci-tec UK Ltd. announces the release of a new Non Coherent Light Source for the activation of medical protocols currently under investigation within the field of Photodynamic Therapy (PDT) Media Coverage Wall Street raises over $150 million for PDT companies (Miravant and QLT). Recently there have been some excellent articles on the current state of PDT and its potential. See an on-line copy from: Forbes Sunday Times Wall Street Journal Photonics Spectra Investor Business Daily New York Times San Francisco Chronicle
© 1996-2008 MBG Technologies